Last Updated: 11/05/2023
Optimisation of the supportive care of adults with severe falciparum malaria
Objectives
To optimise the supportive care of adults with severe falciparum malaria.
In the last two decades the care of patients with severe malaria has been revolutionised by the discovery of new drugs that reduce the chance of dying by 30% when compared to the previous standard treatments. However even with the use of these drugs, up to 30% of adults and 10% of children with severe malaria will still die from the disease. A greater understanding of how malaria harms people is required so that we might develop new drugs and treatment strategies to improve outcomes.
Jan 2013 — Dec 2017
$197,512